JSN Healthcare

The 14 mg Rybelsus (semaglutide) tablet is a prescription medicine primarily used for adults to treat Type 2 diabetes mellitus and to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in patients with Type 2 diabetes who are at high risk for these events. 

Rybelsus 7 mg (semaglutide) tablets are primarily used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes. It is also approved to reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults with type 2 diabetes who are at high risk for these events. 

The 3 mg Rybelsus (semaglutide) tablet is the starting dose used primarily for the management of type 2 diabetes in adults, in addition to diet and exercise.